EN | FR
EN | FR
Search

Cardiopulmonary Impact of Wildfire Smoke

As global temperatures rise, wildfires are increasingly recognized as major public health crises. Exposure to wildfire smoke is known to worsen respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).

Breathing Life into Nanodrug Research: A Lung-on-Chip Revolution

When it comes to inhaled therapies, one of the biggest challenges is replicating the complex dynamics of human breathing in a controlled lab setting. Traditional aerosol exposure systems often fall short—they can deliver particles, but they don’t mimic the realistic airflow patterns and mucociliary clearance that define our respiratory system.

Comparative Analysis of Combustible and Electronic Cigarette Exposure

Combustible and Electronic Cigarette

While combustible cigarette smoke (CCS) is a well-established carcinogen, the oncogenic potential of electronic cigarette vapor (ECV) remains underexplored. A recent study led by Dr. Moghaddam et al. at The University of Texas MD Anderson Cancer Center provides a rigorous comparative analysis of CCS and ECV exposure in a KRAS-mutant lung adenocarcinoma (KM-LUAD) mouse model.

Longitudinal Studies with SCIREQ Systems

Longitudinal studies offer a wealth of information, particularly for diseases progression or development studies. In addition, smaller sample sizes are possible to accumulate significant data, as subject assessment is possible at multiple time points.

Animal Models for Pulmonary Diseases

Animal models are crucial in advancing our knowledge and understanding of pulmonary diseases. Using alternatives models, such as computer simulations, is simply not advanced enough to elucidate all the biological mechanisms inside a living creature.

inExpose featured in Nature publication

Congratulations to Dr. Blackwell’s team at Vanderbilt University who recently published in Nature Communications1 with the inExpose!

As you may know, chronic obstructive pulmonary disease (COPD) is characterized by obstruction in airflow, chronic inflammation, and destruction of the alveolar tissue. This group from Vanderbilt University hypothesized that secretory immunoglobulin A (SIgA) deficiency contributes to chronic airway inflammation and COPD disease progression.